Toxic Epidermal Necrolysis complicating Infliximab therapy in Refractory Kawasaki disease
Keimyung Medical Journal · 2020
DOI: 10.46308/kmj.2020.00094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Keimyung Medical Journal, 2020. Verfasst von Abraham Kwak und 2 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Severe skin reactions complicating tumor necrosis factor-alpha (TNF-α) antagonist therapy were somewhat reported in adults.We report a case of 24-month-old boy with refractory Kawasaki disease who developed toxic epidermal necrolysis (TEN) after one dose of 5mg/kg infliximab.The patient responded to intravenous hydrocortisone and was able to discharge without any other serious complications.The clinicians should be aware of the potential for severe skin reactions from the use of TNF-α antagonists in children.
Zitieren
APA
Kwak, A., Kim, S. A., & Choi, H. J. (2020). Toxic Epidermal Necrolysis complicating Infliximab therapy in Refractory Kawasaki disease. Keimyung Medical Journal. https://doi.org/10.46308/kmj.2020.00094
Vancouver
Kwak A, Kim SA, Choi HJ. Toxic Epidermal Necrolysis complicating Infliximab therapy in Refractory Kawasaki disease. Keimyung Medical Journal. 2020. doi:10.46308/kmj.2020.00094
BibTeX
@article{Kwak2020,
author = {Kwak, Abraham and Kim, Sung Ae and Choi, Hee Joung},
title = {Toxic Epidermal Necrolysis complicating Infliximab therapy in Refractory Kawasaki disease},
journal = {Keimyung Medical Journal},
year = {2020},
doi = {10.46308/kmj.2020.00094}
}
EUVIMED